Related Experiment Video
Updated: Aug 18, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
Published on: April 17, 2026
MdmX inhibits ARF mediated Mdm2 sumoylation
Mithua Ghosh1, Karen Weghorst, Steven J Berberich
1Department of Biochemistry and Molecular Biology, Wright State University, Dayton, Ohio 45435, USA.
Abstract:
Mdm2, by virtue of an intrinsic E3 ubiquitin ligase activity, is capable of autoubiquitination and the ubiquitination of the p53 tumor suppressor protein. Additionally, Hdm2 has been reported to undergo a p14ARF-dependent sumoylation with concurrent Hdm2 stabilization. In this present work, we report that MdmX can undergo ARF-mediated sumoylation similar to that reported for Mdm2. When coexpressed, MdmX overexpression results in a dose-dependent inhibition of Mdm2 sumoylation and a concurrent increase in Mdm2 ubiquitination. This switch from Mdm2 sumoylation to Mdm2 ubiquitination may explain the destablization of Mdm2 previously observed in cells overexpressing both ARF and MdmX. Given that MdmX can heterodimerize with Mdm2 and separately associate with ARF we employed a series of MdmX mutants to examine how MdmX blocks Mdm2 sumoylation. A MdmX miniprotein capable of binding to ARF, but not p53 or Mdm2 was able to competitively inhibit Mdm2 sumoylation and reverse ARF mediated activation of p53 transactivation. Taken together, these results demonstrate that MdmX can affect post-translational modification and stability of Mdm2 and p53 activity through interaction with ARF.
Insights
MdmX protein influences Mdm2 stability and p53 activity by interacting with ARF. MdmX shifts Mdm2 from sumoylation to ubiquitination, impacting tumor suppression.
Area of Science:
- Molecular Biology
- Cancer Research
- Protein Biochemistry
Background:
- Mouse double minute 2 homolog (Mdm2) possesses E3 ubiquitin ligase activity, mediating its own ubiquitination and that of the p53 tumor suppressor.
- Mdm2 undergoes p14ARF-dependent sumoylation, leading to its stabilization.
- MdmX is a related protein that can interact with both Mdm2 and p53.
Purpose of the Study:
- To investigate the effect of MdmX on Mdm2 post-translational modifications, specifically sumoylation and ubiquitination.
- To elucidate the role of MdmX in modulating Mdm2 stability and p53 activity in the presence of ARF.
- To determine the mechanism by which MdmX interferes with Mdm2 sumoylation.
Main Methods:
- Coexpression of MdmX and Mdm2 in cellular systems.
- Analysis of Mdm2 sumoylation and ubiquitination levels.
- Utilized MdmX mutants to dissect protein-protein interactions with ARF, Mdm2, and p53.
Main Results:
- MdmX undergoes ARF-mediated sumoylation, similar to Mdm2.
- MdmX overexpression dose-dependently inhibits Mdm2 sumoylation and increases Mdm2 ubiquitination.
- A MdmX mutant binding ARF but not Mdm2 or p53 competitively inhibited Mdm2 sumoylation and reversed ARF-mediated p53 activation.
Conclusions:
- MdmX directly impacts Mdm2 post-translational modification and stability through ARF interaction.
- MdmX can switch Mdm2 from a sumoylated (stabilized) state to a ubiquitinated (potentially destabilized) state.
- These findings reveal a novel regulatory mechanism for Mdm2 and p53 activity involving MdmX and ARF.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
DNA Damage can Stall the Cell Cycle
Anaphase Promoting Complex
MAPK Signaling Cascades
